Press Coverage
Sofinnova Crossover
Tom Burt, partner at Sofinnova Partners, speaks at Edison Group’s Open House Global Healthcare Event
Related Strategy
CrossoverTom Burt, partner at Sofinnova Partners, joined Edison Group’s Open House Global Healthcare Event. His panel discussed some of the scenarios that are likely to play out in 2022 for biotech in public and private equity markets and M&A. View the replay here.
Related News
Inventiva announces pricing of upsized public offering of approximately $150M American Depositary Shares
Abivax announces patient-reported outcomes data from the Phase 3 ABTECT Induction Trials of Obefazimod, demonstrating significant improvements in quality of life for patients with moderate-to-severely active ulcerative colitis
Hemab Therapeutics announces $157 million Series C financing to advance next-generation treatments for underserved bleeding disorders
Inventiva Appoints Andrew Obenshain as Chief Executive Officer
Artios Pharma Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development